[pH-sensitive polymeric micelles for the effective delivery of anti-cancer drug]. 2007

Kun Na
Department of Biotechnology, The Catholic University of Korea, Bucheon, Korea. kna6997@catholic.ac.kr

Polymeric micelles from pH-sensitive block copolymers have been designed for targeting tumor acidity or endosomal pH in tumor cells. The micelles are core-shell types formed by self-organization of the blocks in an aqueous medium or under specific experimental conditions. They possess a segment that has physical or chemical properties responding to small changes in environmental pH. The segment induces to the fast release kinetics from the micelles at tumor sites by particle shrunk/disruption. Furthermore, it can alter the biodistribution of the micelles and the interactions with tissues and cells by utilizing small pH changes. Such properties lead to overcome the problems associated with free chemo-agents, such as nonspecific toxicity, lack of tumor selectivity, and the development of multidrug resistance in various tumor cells. Therefore, the micelles have been considered as promising anti-cancer drug carriers. This review summarizes the recent progress in pH-sensitive micelles for tumor chemotherapy, particularly for those responding to tumor pH and endosomal/lysosomal pH for the treatment of multidrug resistance (MDR).

UI MeSH Term Description Entries
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug

Related Publications

Kun Na
November 2010, Pharmaceutical research,
Kun Na
January 2012, Current pharmaceutical design,
Kun Na
September 2017, Materials science & engineering. C, Materials for biological applications,
Kun Na
February 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Kun Na
March 2011, Journal of nanoscience and nanotechnology,
Kun Na
January 2017, Journal of controlled release : official journal of the Controlled Release Society,
Copied contents to your clipboard!